Aminocaproyl-Val-Cit-PABC-MMAE

• UNSPSC Description:

  Aminocaproyl-Val-Cit-PABC-MMAE is an Drug-linker conjugate for ADC[1].

• Target Antigen:

  Drug-Linker Conjugates for ADC

• Type:

  Reference compound

• Related Pathways:

  Antibody-drug Conjugate/ADC Related

• Applications:

  Cancer-programmed cell death

• Field of Research:

  Cancer

• Assay Protocol:

  https://www.medchemexpress.com/aminocaproyl-val-cit-pabc-mmae.html

• Purity:

  99.97

• Solubility:

  DMSO : 200 mg/mL (ultrasonic)

• Smiles:

  CC(C)[C@@H](C(N[C@@H](CCCNC(N)=O)C(NC1=CC=C(COC(N(C)[C@@H](C(C)C)C(N[C@@H](C(C)C)C(N([C@@H]([C@@H](C)CC)[C@H](OC)CC(N2[C@@]([C@H](OC)[C@@H](C)C(N[C@H](C)[C@@H](O)C3=CC=CC=C3)=O)([H])CCC2)=O)C)=O)=O)=O)C=C1)=O)=O)NC(CCCCCN)=O

• Molecular Weight:

  1236.58

• References & Citations:

  [1]Pavel Strop, et al. Antibody-drug conjugates with high drug loading. Patent. WO2015162563.

• Shipping Conditions:

  Blue Ice

• Storage Conditions:

  -20°C (Powder, sealed storage, away from moisture)

• Clinical Information:

  No Development Reported

• CAS Number:

  1374407-35-8